UMeWorld Limited (UMEWF) research, news, and more from GeoInvesting

Company description

Sat, 25 Feb 2012 05:00:00 GMT

ALPHARx, INC. (the “Company”) was incorporated under the laws of the State of Delaware on August 7, 1997. The Company was engaged in the development of proven therapies by reformulating FDA approved and marketed drugs using its proprietary drug delivery technology. On November 4, 2011 the Company terminated its drug development business and to pursue acquisition opportunities in digital media with an intense focus on China.

Comments & Business Outlook

Fri, 30 Jan 2015 05:00:00 GMT

UMEWORLD LIMITED

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR THE YEARS ENDED SEPTEMBER 30, 2014, 2013 AND 2012

(All amounts in US Dollars)

	2014			2013			2012

License Fees and Royalties	$	-		$	760,329		$	166,803
TOTAL REVENUES		-			760,329			166,803

General and Administrative Expenses		1,076,086			994,931			404,791
Goodwill impairment (Note 15)		-			19,425,346			-
Stock-based Compensation		2,692,960			-			-
Depreciation		4,804			3,452			2,280
LOSS FROM OPERATIONS		(3,773,850	)		(19,663,400	)		(240,268	)

OTHER INCOME
Other income		13,364			106,377			244,325
Interest income		409			2,704			682
OTHER EXPENSES
Interest Expense, net		(96,670	)		(88,348	)		(97,632	)
LOSS BEFORE INCOME TAXES		(3,856,747	)		(19,642,667	)		(92,893	)

INCOME TAX (Note 10)		-			-			-
Net Loss		(3,856,747	)		(19,642,667	)		(92,893	)
Net (Income)/Loss attributable to Non-Controlling interests		(15,624	)		(15,620	)		15,604
Net Gain/(Loss) attributable to UMeWorld Limited Stockholders		(3,872,371	)		(19,658,287	)		(77,289	)

Comprehensive Loss
Net Gain/(Loss)		(3,872,371	)		(19,658,287	)		(77,289	)
Translation Adjustment		1,174			4,346			(315	)
Comprehensive Gain/(Loss)		(3,871,197	)		(19,653,941	)		(77,604	)
Less: Comprehensive Income Attributable to Non-Controlling Interests		235			(869	)		(63	)
Comprehensive Gain/(Loss) Attributable to UMeWorld Limited Stockholders		(3,870,962	)		(19,654,810	)		(77,667	)

Per Share Data
Net Loss Per Share, basic and diluted	$	(0.0435	)	$	(0.2208	)	$	(0.0031	)
Weighted Average Number of Common Shares Outstanding		89,036,000			89,036,000			25,023,148

Management Discussion and Analysis

Revenues

Revenues totaled $0 for the year ended September 30, 2014 as compared to $760,329 generated for the year ended September 30, 2013, a decrease of $760,329 or 100%. The decrease in revenues was mainly due to the disposal of Indaflex rights in Mexico to Andromaco.

Loss from Continuing Operations and Net Loss

As a result of the above revenues and expenses, we incurred a loss from continuing operations of $3,872,371 for the year ended September 30, 2014 as compared to $19,642,667 incurred loss for the same period a year ago, a decrease of $15,677,403 or about 80%. Revenues decreased by $760,329 and expenses decreased by $15,889,550 in the year ended September 30, 2014 as compared to the previous year.

Comments & Business Outlook

Thu, 13 Feb 2014 05:00:00 GMT

20-F

UMEWORLD LIMITED

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR THE YEARS ENDED SEPTEMBER 30, 2013, 2012 AND 2011

(All amounts in US Dollars)

	2013			2012			2011

License Fees and Royalties	$	760,329		$	166,803		$	158,166
Consulting Revenues		-			-			25,337
TOTAL REVENUES		760,329			166,803			183,503

General and Administrative Expenses		994,931			404,791			374,676
Research and Development Expenses		-			-			16,609
Depreciation		3,452			2,280			33,698
LOSS FROM OPERATIONS		(238,054	)		(240,268	)		(241,480	)

OTHER INCOME
Other income		106,377			244,325			83,292
Interest income		2,704			682			-

OTHER EXPENSES
Interest Expense, net		(88,348	)		(97,632	)		(103,872	)
LOSS BEFORE INCOME TAXES		(217,321	)		(92,893	)		(262,060	)

INCOME TAX (Note 10)		-			-			-
Net Loss		(217,321	)		(92,893	)		(262,060	)
Net (Income)/Loss attributable to Non-Controlling interests		(15,620	)		15,604			-
Net Gain/(Loss) attributable to UMeWorld Limited Stockholders		(232,941	)		(77,289	)		(262,060	)

Comprehensive Loss
Net Gain/(Loss)		(232,941	)		(92,893	)		(262,060	)
Translation Adjustment		4,346			(315	)		(3,726	)
Comprehensive Gain/(Loss)		(228,595	)		(93,208	)		(265,786	)
Less: Comprehensive Income Attributable to Non-Controlling Interests		(869	)		(63	)		(745	)
Comprehensive Gain/(Loss) Attributable to UMeWorld Limited Stockholders		(229,464	)		(93,271	)		(266,531	)

Per Share Data
Net Loss Per Share, basic and diluted	$	(0.0026	)	$	(0.0037	)	$	(0.014	)
Weighted Average Number of Common Shares Outstanding		89,036,000			25,023,148			18,960,489